{"id":419776,"date":"2021-01-22T17:17:11","date_gmt":"2021-01-22T22:17:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=419776"},"modified":"2021-01-22T17:17:11","modified_gmt":"2021-01-22T22:17:11","slug":"seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/","title":{"rendered":"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA"},"content":{"rendered":"

<\/p>\n

\nSENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA\n<\/p>\n

NEW ORLEANS–(BUSINESS WIRE<\/a>)–
\nFormer Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d) are investigating the proposed merger of Seneca Biopharma, Inc. (NasdaqGS: SNCA) with Leading BioSciences, Inc. pursuant to which Seneca shareholders will own just 26.2% of the surviving combined entity. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.\n<\/p>\n

\nIf you believe that this transaction undervalues the Company and\/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com<\/a>) toll free at any time at 855-768-1857, or visit https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-snca\/<\/a> to learn more.\n<\/p>\n

\nTo learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210122005478\/en\/<\/a><\/span><\/p>\n

\nKahn Swick & Foti, LLC
\n
Lewis S. Kahn, 855-768-1857
\n
KSF Managing Partner
\n
lewis.kahn@ksfcounsel.com<\/a><\/p>\n

KEYWORDS:<\/b> Louisiana United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA NEW ORLEANS–(BUSINESS WIRE)– Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d) are investigating the proposed merger of Seneca Biopharma, Inc. (NasdaqGS: SNCA) with Leading BioSciences, Inc. pursuant to which Seneca shareholders will own just 26.2% of the surviving combined entity. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you believe that this transaction undervalues the Company and\/or if you would like to discuss your legal rights … <\/p>\n

Continue reading “SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-419776","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. - SNCA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. - SNCA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA NEW ORLEANS–(BUSINESS WIRE)– Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d) are investigating the proposed merger of Seneca Biopharma, Inc. (NasdaqGS: SNCA) with Leading BioSciences, Inc. pursuant to which Seneca shareholders will own just 26.2% of the surviving combined entity. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you believe that this transaction undervalues the Company and\/or if you would like to discuss your legal rights … Continue reading "SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-22T22:17:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA\",\"datePublished\":\"2021-01-22T22:17:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/\",\"name\":\"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. - SNCA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-22T22:17:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. - SNCA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/","og_locale":"en_US","og_type":"article","og_title":"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. - SNCA - Market Newsdesk","og_description":"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA NEW ORLEANS–(BUSINESS WIRE)– Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d) are investigating the proposed merger of Seneca Biopharma, Inc. (NasdaqGS: SNCA) with Leading BioSciences, Inc. pursuant to which Seneca shareholders will own just 26.2% of the surviving combined entity. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you believe that this transaction undervalues the Company and\/or if you would like to discuss your legal rights … Continue reading \"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-22T22:17:11+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA","datePublished":"2021-01-22T22:17:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/","name":"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. - SNCA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-22T22:17:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210122005478r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seneca-biopharma-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-merger-of-seneca-biopharma-inc-snca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. – SNCA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/419776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=419776"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/419776\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=419776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=419776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=419776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}